-
1
-
-
0036169930
-
Guidelines for the management of rheumatoid arthritis: 2002 update
-
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines, Feb;
-
American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002 Feb; 46 (2): 328-46
-
(2002)
Arthritis Rheum
, vol.46
, Issue.2
, pp. 328-346
-
-
-
2
-
-
0036083066
-
Leflunomide for the treatment of rheumatoid arthritis and autoimmunity
-
Sanders S, Harisdangkul V. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity. Am J Med Sci 2002; 323: 190-3
-
(2002)
Am J Med Sci
, vol.323
, pp. 190-193
-
-
Sanders, S.1
Harisdangkul, V.2
-
4
-
-
0036000248
-
Leflunomide and hypertension
-
Jun;
-
Rozman B, Praprotnik S, Logar D, et al. Leflunomide and hypertension. Ann Rheum Dis 2002 Jun; 61 (6): 567-9
-
(2002)
Ann Rheum Dis
, vol.61
, Issue.6
, pp. 567-569
-
-
Rozman, B.1
Praprotnik, S.2
Logar, D.3
-
5
-
-
0036310615
-
Clinical pharmacokinetics of leflunomide
-
Rozman B. Clinical pharmacokinetics of leflunomide. Clin Pharmacokinet 2002; 41: 421-30
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 421-430
-
-
Rozman, B.1
-
6
-
-
0030068817
-
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis
-
Van Gestel AM, Prevoo ML, Van't Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis Rheum 1996; 39: 34-40
-
(1996)
Arthritis Rheum
, vol.39
, pp. 34-40
-
-
Van Gestel, A.M.1
Prevoo, M.L.2
Van't Hof, M.A.3
-
7
-
-
51849089097
-
Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries
-
Sep;
-
Sokka T, Hetland ML, Makinene H, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008 Sep; 58 (9): 2642-51
-
(2008)
Arthritis Rheum
, vol.58
, Issue.9
, pp. 2642-2651
-
-
Sokka, T.1
Hetland, M.L.2
Makinene, H.3
-
8
-
-
33947112508
-
Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient
-
Ranganath VK, Furst DE. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient. Rheum Dis Clin North Am 2007; 33: 197-217
-
(2007)
Rheum Dis Clin North Am
, vol.33
, pp. 197-217
-
-
Ranganath, V.K.1
Furst, D.E.2
-
9
-
-
33747768640
-
Do patients with older onset rheumatoid arthritis receive less aggressive treatment?
-
Tutuncu A, Reed G, Kremer J, et al. Do patients with older onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 2006; 65: 1226-9
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1226-1229
-
-
Tutuncu, A.1
Reed, G.2
Kremer, J.3
-
10
-
-
34547785985
-
Treatment of older adult patients diagnosed with rheumatoid arthritis: Improved but not optimal
-
Aug 15;
-
Schmajuk G, Schneeweiss S, Katz JN, et al. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007 Aug 15; 57 (6): 928-34
-
(2007)
Arthritis Rheum
, vol.57
, Issue.6
, pp. 928-934
-
-
Schmajuk, G.1
Schneeweiss, S.2
Katz, J.N.3
-
11
-
-
18044400396
-
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate
-
Cohen S, Cannon GW, Schiff M, et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum 2001; 44: 1984-92
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1984-1992
-
-
Cohen, S.1
Cannon, G.W.2
Schiff, M.3
-
12
-
-
0034877904
-
Improved functional ability in patients with rheumatoid arthritis: Long-term treatment with leflunomide versus sulfasalazine
-
Kalden JR, Scott DL, Smolen JS, et al. Improved functional ability in patients with rheumatoid arthritis: long-term treatment with leflunomide versus sulfasalazine. J Rheumatol 2001; 28: 1983-91
-
(2001)
J Rheumatol
, vol.28
, pp. 1983-1991
-
-
Kalden, J.R.1
Scott, D.L.2
Smolen, J.S.3
-
13
-
-
34548487507
-
Leflunomide in psoriatic arthritis
-
Kaltwasser JP. Leflunomide in psoriatic arthritis. Autoimmun Rev 2007; 6: 511-4
-
(2007)
Autoimmun Rev
, vol.6
, pp. 511-514
-
-
Kaltwasser, J.P.1
-
14
-
-
11344271068
-
Six months open label trial of leflunomide in active ankylosing spondylitis
-
Jan;
-
Haibel H, Rudwaleit M, Braun J, et al. Six months open label trial of leflunomide in active ankylosing spondylitis. Ann Rheum Dis 2005 Jan; 64 (1): 124-6
-
(2005)
Ann Rheum Dis
, vol.64
, Issue.1
, pp. 124-126
-
-
Haibel, H.1
Rudwaleit, M.2
Braun, J.3
-
15
-
-
0036328556
-
Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis
-
Nurmohamed MT, van Halm VP, Dijkmans BA. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis. Drugs 2002; 62: 1599-609
-
(2002)
Drugs
, vol.62
, pp. 1599-1609
-
-
Nurmohamed, M.T.1
van Halm, V.P.2
Dijkmans, B.A.3
-
16
-
-
0033596065
-
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group
-
Strand V, Cohen S, Schiff M, et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med 1999; 22 (159): 2542-50
-
(1999)
Arch Intern Med
, vol.22
, Issue.159
, pp. 2542-2550
-
-
Strand, V.1
Cohen, S.2
Schiff, M.3
-
17
-
-
34347377582
-
Trends in hypertension prevalence, awareness, treatment, and control in older US adults: Data from the National Health and Nutrition Examination Survey 1988 to 2004
-
Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55: 1056-65
-
(2007)
J Am Geriatr Soc
, vol.55
, pp. 1056-1065
-
-
Ostchega, Y.1
Dillon, C.F.2
Hughes, J.P.3
|